Eli Lilly, Morphic face July 31 US antitrust deadline
Eli Lilly and biotech company Morphic Holding have filed paperwork for their $3.2 billion deal with the US antitrust authorities. The initial waiting period under the Hart-Scott-Rodino Act is expected to...To view the full article, register now.
Already a subscriber? Click here to view full article